Literature DB >> 2783993

Treatment of trigeminal neuralgia by thermocoagulation, glycerolization, and percutaneous compression of the gasserian ganglion and/or retrogasserian rootlets: long-term results and therapeutic protocol.

B Fraioli1, V Esposito, B Guidetti, G Cruccu, M Manfredi.   

Abstract

From 1976 to 1986, 681 patients with drug-refractory trigeminal neuralgia (TN)--typical in 641, symptomatic of multiple sclerosis in 23 and of tumor in 10, atypical in 5, and postherpetic in 2--were treated with various percutaneous procedures. Controlled differential thermocoagulation of the gasserian ganglion and/or retrogasserian rootlets was performed in 533 patients; glycerolization of the trigeminal cistern in 32; and compression of the gasserian ganglion by balloon catheter in 159. Results and complications of each procedure are assessed at a mean follow-up of 6.5 years for thermocoagulation, 5 years for glycerolization, and 3.5 years for compression. The following therapeutic protocol is proposed: 1) in TN patients at first operation: a) gasserian compression (or glycerolization, if experience warrants it) is indicated in all cases of typical TN, unless the 3rd division alone is affected; b) in the latter case and in symptomatic TN, we suggest thermocoagulation; 2) in recurrences: a) after glycerolization or gasserian compression, gasserian compression (or glycerolization) is indicated; b) after thermocoagulation or open surgery, thermocoagulation is suggested.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2783993     DOI: 10.1227/00006123-198902000-00014

Source DB:  PubMed          Journal:  Neurosurgery        ISSN: 0148-396X            Impact factor:   4.654


  27 in total

1.  Metastatic involvement of the Meckel's cave and trigeminal nerve. A case report.

Authors:  L Mastronardi; P Lunardi; J Osman Farah; F Puzzilli
Journal:  J Neurooncol       Date:  1997-03       Impact factor: 4.130

2.  Advanced age as a contraindication to microvascular decompression for drug-resistant trigeminal neuralgia: evidence of prejudice?

Authors:  Paolo Ferroli; Francesco Acerbi; Massimo Tomei; Giovanni Tringali; Angelo Franzini; Giovanni Broggi
Journal:  Neurol Sci       Date:  2009-10-06       Impact factor: 3.307

3.  Relation between sensory disturbance and outcome after retrogasserian glycerol rhizotomy.

Authors:  A T Bergenheim; M I Hariz; L V Laitinen; M Olivecrona; L Rabow
Journal:  Acta Neurochir (Wien)       Date:  1991       Impact factor: 2.216

4.  Treatment of chronic facial pain.

Authors:  Norah S Lincoff
Journal:  Curr Treat Options Neurol       Date:  2006-01       Impact factor: 3.598

5.  Percutaneous balloon compression of the Gasserian ganglion in trigeminal neuralgia. Long-term results in 150 cases.

Authors:  B Abdennebi; F Bouatta; M Chitti; B Bougatene
Journal:  Acta Neurochir (Wien)       Date:  1995       Impact factor: 2.216

6.  Long-term results after percutaneous retrogasserian glycerol rhizotomy in patients with trigeminal neuralgia.

Authors:  H Slettebø; H Hirschberg; K F Lindegaard
Journal:  Acta Neurochir (Wien)       Date:  1993       Impact factor: 2.216

7.  Percutaneous selective radio-frequency neuroablation in plastic surgery.

Authors:  G Hernández-Zendejas; J Guerrero-Santos
Journal:  Aesthetic Plast Surg       Date:  1994       Impact factor: 2.326

8.  Prognostic factors in the treatment of trigeminal neuralgia. Analysis of a differential therapeutic approach.

Authors:  H J Steiger
Journal:  Acta Neurochir (Wien)       Date:  1991       Impact factor: 2.216

Review 9.  Choosing drug therapy for multiple sclerosis. An update.

Authors:  B W van Oosten; L Truyen; F Barkhof; C H Polman
Journal:  Drugs       Date:  1998-10       Impact factor: 9.546

10.  [Trigeminal neuralgia-how patients experience their condition disease.].

Authors:  M Mohadjer; R Scheremet; R H Kutschera; H R Eggert
Journal:  Schmerz       Date:  1995-01       Impact factor: 1.107

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.